BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.61B |
| 2 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$866M |
| 3 |
Healthcare Realty
HR
|
+$716M |
| 4 |
CoStar Group
CSGP
|
+$588M |
| 5 |
Annaly Capital Management
NLY
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.33B |
| 2 |
Chevron
CVX
|
+$1.04B |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$1.02B |
| 4 |
ACC
American Campus Communities, Inc.
ACC
|
+$1.01B |
| 5 |
Microsoft
MSFT
|
+$979M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Healthcare | 15.27% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.35% |
| 5 | Industrials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRVN
4526
DELISTED
Trevena, Inc.
TRVN
| $430K | ﹤0.01% |
4,493
-5
| -0.1% | -$767 |
|
|
OPNT
4527
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $429K | ﹤0.01% |
39,922
+127
| +0.3% | +$1.44K |
|
|
TBHC
4528
DELISTED
The Brand House Collective
TBHC
| $428K | ﹤0.01% |
142,008
-1,219
| -0.9% | -$4.69K |
|
|
CBIO
4529
Crescent Biopharma
CBIO
$537M
| $423K | ﹤0.01% |
7,659
-24
| -0.3% | -$1.73K |
|
|
RVLP
4530
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $423K | ﹤0.01% |
201,419
-5,759
| -3% | -$11.2K |
|
|
LOTZ
4531
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
| $423K | ﹤0.01% |
1,411,862
-9,004
| -0.6% | -$3.94K |
|
|
SCPH
4532
DELISTED
scPharmaceuticals
SCPH
| $422K | ﹤0.01% |
64,802
+14
| +0% | +$75 |
|
|
CORR
4533
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $421K | ﹤0.01% |
264,612
-50,324
| -16% | -$113K |
|
4534
CPS Technologies
CPSH
$75.5M
| $420K | ﹤0.01% |
149,482
-8,961
| -6% | -$30.4K |
|
4535
Sixth Street Specialty
TSLX
$1.63B
| $420K | ﹤0.01% |
25,738
+3,753
| +17% | +$69.9K |
|
4536
Arcos Dorados Holdings
ARCO
$1.72B
| $416K | ﹤0.01% |
56,997
-37,114
| -39% | -$267K |
|
|
ELVT
4537
DELISTED
Elevate Credit, Inc.
ELVT
| $416K | ﹤0.01% |
378,856
+481
| +0.1% | +$872 |
|
4538
Natural Health Trends
NHTC
$14.7M
| $412K | ﹤0.01% |
112,075
-9,883
| -8% | -$49.8K |
|
4539
Compugen
CGEN
$222M
| $411K | ﹤0.01% |
625,801
-18,216
| -3% | -$25.7K |
|
4540
Corvus Pharmaceuticals
CRVS
$1.12B
| $411K | ﹤0.01% |
502,942
-2,624
| -0.5% | -$2.5K |
|
|
SYBX
4541
DELISTED
Synlogic
SYBX
| $410K | ﹤0.01% |
28,702
-211
| -0.7% | -$3.23K |
|
4542
Quest Resource Holding
QRHC
$26.8M
| $408K | ﹤0.01% |
48,272
-784
| -2% | -$4.59K |
|
4543
Talphera
TLPH
$66.4M
| $407K | ﹤0.01% |
97,357
+999
| +1% | +$5.23K |
|
4544
Vanguard Russell 1000 Value ETF
VONV
$20.7B
| $407K | ﹤0.01% |
6,825
+6,793
| +21,228% | +$447K |
|
|
LGVN
4545
Longeveron
LGVN
$22.2M
| $406K | ﹤0.01% |
10,973
-27
| -0.2% | -$1.49K |
|
4546
Pyxis Oncology
PYXS
$168M
| $406K | ﹤0.01% |
206,554
+1,250
| +0.6% | +$3.27K |
|
|
TSPQ
4547
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
| $403K | ﹤0.01% |
41,121
+31,121
| +311% | +$305K |
|
4548
Fennec Pharmaceuticals
FENC
$332M
| $399K | ﹤0.01% |
49,367
-2,002
| -4% | -$13.7K |
|
|
REV
4549
DELISTED
Revlon, Inc.
REV
| $399K | ﹤0.01% |
77,153
+57,907
| +301% | +$376K |
|
4550
iShares MSCI Hong Kong ETF
EWH
$1.24B
| $397K | ﹤0.01% |
21,785
+21,713
| +30,157% | +$449K |
|
Similar funds
BlackRock's Q3 2022 Portfolio in Review
As of Q3 2022, BlackRock held 6,072 positions worth $2.94T, down 5.7% from $3.12T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2022 filing shows 155 new, 2,153 increased, 2,890 reduced and 201 closed positions. Its largest new stake was Enhabit: 6,943,848 shares worth $97.5M. The largest sale was Apple, an estimated $1.33B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2022 buy was Enhabit: 6,943,848 shares worth $97.5M.
- BlackRock added most to Tesla in Q3 2022, an estimated $1.61B increase.
- BlackRock's biggest Q3 2022 reduction was Apple, cutting an estimated $1.33B.
- BlackRock fully exited CDK Global, Inc. in Q3 2022, selling an estimated $1.02B.
- BlackRock's ten largest holdings make up 19% of its $2.94T portfolio in Q3 2022.
- BlackRock opened 155 new positions and closed 201 in Q3 2022.
- BlackRock's portfolio value fell 5.7% quarter-over-quarter to $2.94T.
Based on BlackRock's 13F filing for Q3 2022, filed 14 Nov 2022.